Buprenorphine Hcl 00406-7012
Product NDC
00406-7012- Manufacturer
- Specgx Llc
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- January 19, 2026
- Listing Expires
- December 31, 2026
- Application
- ANDA218473
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 2 mg/1 |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Packaging Options(1)
30 TABLET in 1 BOTTLE (0406-7012-03)